Evidence map›Paper›PMID 41432846›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Variability and interpretability of benzylpenicillin inhibition zone edges in Staphylococcus aureus - a multi-center study in Austria.

Felix Lötsch, David N Springer, Brigitte Selitsch, Sonja Lener, Barbara Ströbele, Lamiss Mejdoubi, Philipp Grubwieser, Silke Huber, Dieter Mitteregger, Harald Dirschmid and 4 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Felix LötschDivision of Clinical Microbiology, Clinical Institute of Laboratory Medicine, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria. felix.loetsch@meduniwien.ac.at.
David N SpringerCenter for Virology, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria.
Brigitte SelitschDivision of Clinical Microbiology, Clinical Institute of Laboratory Medicine, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Sonja LenerDepartment of Microbiology, Mühl-Speiser-Bauer-Spitzauer and Partner Labors.at OG, Kürschnergasse 6B, Vienna, 1210, Austria.
Barbara StröbeleClinical Institute for Hygiene and Microbiology, University Hospital St. Pölten, Dunantplatz 1, St. Pölten, 3100, Austria.
Lamiss MejdoubiDepartment of Clinical Microbiology, Institute of Pathology and Microbiology, Hanusch Hospital, Heinrich-Collin Strasse 30, Vienna, 1140, Austria.
Philipp GrubwieserInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria.
Silke HuberInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria.
Dieter MittereggerDepartment of Clinical Microbiology, Institute of Clinical Pathology, Cytology and Microbiology, Dr. Kosak GmbH, Mariannengasse 14, Vienna, 1090, Austria.
Harald DirschmidInstitute for Pathology, Landeskrankenhaus Feldkirch, Carinagasse 47, Feldkrich, 6800, Austria.
Verena SchliesserInstitute of Laboratory Diagnostic and Microbiology, Klinikum Klagenfurt am Wörthersee, Feschnigstrasse 11, Klagenfurt, 9020, Austria.
Alexandra WojnaDepartment of Clinical Microbiology and Hygiene, MEDILAB-Labor- GesmbH, Academic Teaching Laboratory of Paracelsus Medical University (PMU)-Salzburg, Strubergasse 20, Salzburg, 5020, Austria.
Markus HellDepartment of Clinical Microbiology and Hygiene, MEDILAB-Labor- GesmbH, Academic Teaching Laboratory of Paracelsus Medical University (PMU)-Salzburg, Strubergasse 20, Salzburg, 5020, Austria.
Birgit WillingerDivision of Clinical Microbiology, Clinical Institute of Laboratory Medicine, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBenzylpenicillin is regaining attention as a treatment option for susceptible S. aureus, including in severe invasive diseases such as blood stream infections. Timely and reliable susceptibility determination is essential to support its use in clinical practice. In this study, we assessed the EUCAST-recommended methodology of interpreting zone edges in a national multicenter trial.

methodsIn total, nine microbiology laboratories in Austria participated. Each center received 10 isolates in blinded duplicates, all with inhibition zones of ≥ 26 mm. Three were blaZ-positive with sharp edges and seven were blaZ-negative with fuzzy edges. Benzylpenicillin susceptibility testing according to EUCAST guidelines using 1 unit discs was performed by two independent technicians in duplicate on two separate days. All plates were interpreted by two different assessors generating a total of 1440 data points.

resultsOverall, 85.5% of all interpretations were correct. Both, major and very major errors occurred. There was high variability between laboratories with overall accuracy ranging from 61.9% to 100%. There were statistically significant differences in the average inhibition zone between MH agars from different manufacturers. Laboratories using agars giving rise to a smaller average inhibition zone (i.e. lower diffusion of benzylpenicillin) performed less well. Laboratories with the methodology implemented performed better than those without experience.

conclusionIn summary, our study demonstrates that benzylpenicillin susceptibility testing using the EUCAST-recommended methodology is feasible, but accurate and reproducible assessment of zone edges requires both experience and optimal materials. Thorough validation of locally used materials is therefore essential before implementing this approach for routine use.

Indexed as

Anti-Bacterial AgentsPenicillin GStaphylococcus aureusAustriaHumansMicrobial Sensitivity TestsStaphylococcal InfectionsAnti-Bacterial AgentsPenicillin GAntimicrobial susceptibility testingAustriaBenzylpenicillinEUCASTStaphylococcus aureus

Identifiers

PMID41432846
PMCPMC13086644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.